Skip to content

Global Innovative Platforms

2 viewers · 30d

Total raised

$157K

2 filings since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity
ROUNDS
2
INVESTORS
8
FOUNDED
N/A
HQ
Maitland, FL
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Global Innovative Platforms Inc. (OTC: GIPL) develops non-invasive breath-based diagnostics for animal health through its VetBreath Analytics division. Its platform uses gas chromatography plus cloud-based AI to identify disease-specific volatile organic compounds in a shallow breath sample, returning results in about ten minutes with no blood draw or stool collection. The lead program is a canine heartworm breath test, running an eight-month study with researchers at Auburn University and Oklahoma State and using the shelter Big Dog Ranch Rescue as a high-volume sample collection partner. Additional breath signatures for intestinal parasites, feline disease, livestock and poultry conditions are in development.

What sets it apart

Detects disease from a breath sample at parts-per-trillion sensitivity in minutes, where conventional heartworm antigen testing requires a stressful blood draw and cannot detect infection until roughly six months after exposure.

Funding history

2 rounds
EquityJun 4, 2026 · $5K min
Form D
—$157K total
EquityMay 2, 2025 · $5K min
Form D
+$157K$157K total

Products

1 tracked

VetBreath Dx Breath Analysis Platform

Veterinary diagnostic device

A point-of-care veterinary diagnostic system pairing a breath collection device with gas chromatography instrumentation (VOCAM+ and FROG platforms) and cloud AI that reads disease-specific volatile organic compound signatures.

  • Non-invasive breath sampling, no blood draw or stool sample
  • Gas chromatography reading volatile organic compounds down to parts per trillion
  • Cloud-based, continuously learning AI classification
  • Results in about ten minutes at the point of care

Links

WebsiteSEC EDGAR filings